Modulation de la necrose programmee

Modulation of programmed necrosis

Abstract

L'invention concerne des méthodes de modulation de la nécrose programmée. Lesdites méthodes permettent de moduler des protéines impliquées dans la nécrose programmée, par exemple le récepteur 2 du facteur de nécrose tumorale (TNFR-2), le récepteur 1 du facteur de nécrose tumorale (TNFR-1), et la protéine RIP.
Methods related to modulating programmed necrosis are described. The methods relate to modulation of proteins involved in programmed necrosis, e.g., tumor necrosis factor receptor (2) (TNFR-2), tumor necrosis factor receptor (1) (TNFR-1), and receptor-interacting protein (RIP).

Claims

Description

Topics

Download Full PDF Version (Non-Commercial Use)

Patent Citations (0)

    Publication numberPublication dateAssigneeTitle

NO-Patent Citations (3)

    Title
    FULDA S. ET AL.: "Metabolic Inhibitors Sensitize for CD95 (APO-1/Fas)-Induced Apoptosis by Down-Regulating Fas-Associated Death Domain-like Interleukin 1-Converting Enzyme Inhibitory Protein Expression", CANCER RES., vol. 60, 15 July 2000 (2000-07-15), pages 3947 - 3956, XP003014391
    HOLLER N. ET AL.: "Fast Triggers and Alternative, Caspase-8-Independent Cell Death Pathway Using the Kinase RIP as Effector Molecule", NAT. IMMUNOL., vol. 1, no. 6, December 2000 (2000-12-01), pages 489 - 495, XP001095602
    MORGAN M.J. ET AL.: "An Apoptosis Signaling Pathway Induced by the Death Domain of FADD Selectively Kills Normal but not Cancerous Prostate Epithelial Cells", CELL DEATH DIFFER., vol. 8, 2001, pages 696 - 705, XP003014392

Cited By (0)

    Publication numberPublication dateAssigneeTitle